OBERWEIS ASSET MANAGEMENT INC/ - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 332 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
OBERWEIS ASSET MANAGEMENT INC/ ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$243,000
-43.1%
2,440
-34.8%
0.06%
-29.5%
Q2 2019$427,000
-92.4%
3,740
-91.6%
0.08%
-93.1%
Q1 2019$5,613,000
-4.3%
44,649
+3.3%
1.13%
-14.1%
Q4 2018$5,866,000
-39.9%
43,229
+21.5%
1.31%
-30.7%
Q3 2018$9,768,000
-4.0%
35,587
-27.6%
1.89%
-26.0%
Q2 2018$10,178,000
+26.3%
49,127
+0.7%
2.56%
+20.9%
Q1 2018$8,058,000
-0.8%
48,792
-17.8%
2.12%
+11.3%
Q4 2017$8,127,000
+15.9%
59,352
+15.2%
1.90%
-2.6%
Q3 2017$7,012,000
+16.8%
51,502
+4.1%
1.95%
+18.5%
Q2 2017$6,003,000
+11.4%
49,452
-2.9%
1.65%
+3.7%
Q1 2017$5,390,000
-31.9%
50,922
-34.7%
1.59%
-32.9%
Q4 2016$7,918,000
+4.6%
77,922
+5.1%
2.37%
+8.6%
Q3 2016$7,569,000
-24.8%
74,162
-12.2%
2.18%
-27.2%
Q2 2016$10,071,000
+2.5%
84,442
-8.0%
2.99%
+5.5%
Q1 2016$9,827,000
-10.4%
91,767
-9.3%
2.84%
-7.7%
Q4 2015$10,964,000
+34.2%
101,127
+6.0%
3.08%
+29.2%
Q3 2015$8,168,000
-13.2%
95,367
+2.2%
2.38%
-4.5%
Q2 2015$9,415,000
-2.6%
93,307
-25.6%
2.49%
-8.3%
Q1 2015$9,669,000
+11.9%
125,387
-22.8%
2.72%
+5.3%
Q4 2014$8,641,000
+9.2%
162,387
-3.5%
2.58%
+19.1%
Q3 2014$7,910,000
-28.2%
168,337
-4.8%
2.17%
-20.2%
Q2 2014$11,015,000
-23.4%
176,837
-17.3%
2.72%
-10.0%
Q1 2014$14,378,000
+28.1%
213,737
+0.2%
3.02%
+11.1%
Q4 2013$11,220,000
+74.5%
213,317
+43.6%
2.72%
+48.8%
Q3 2013$6,428,000
+1126.7%
148,532
+960.9%
1.83%
+1125.5%
Q2 2013$524,00014,0000.15%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders